Clinical Trial Update: LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma [NA]

View source ↗

Summary

This clinical trial update indicates that the LCAR-M61SQ therapy for relapsed/refractory multiple myeloma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• LCAR-M61SQ

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Relapsed/Refractory Multiple Myeloma | NA | Status: NOT_YET_RECRUITING